Demand Manager Abbott Laboratories

Mark Sterckel is currently the Demand & Business Excellence Manager at Abbott Laboratories in Montreal Canada. In this role he is responsible for the monthly S&OP process and forecast accuracy improvement. Major relevant achievement in this role; 4 consecutive months no backorders on our pharmaceutical products while lowering DOH. As the Business Excellence manager Mark is responsible to make the commercial organization of 800 people more efficient by using Lean Six Sigma.

Prior to Canada Mark worked for Abbott in the Netherlands for in several supply chain related positions. Mark started his career at Heineken in supply chain and moved on to Ahold before joining Abbott in 2002.

Director, Contract Manufacturing & Logistics Abbott Laboratories

Robert Douglass is currently Director of Global Contract Manufacturing and Logistics at Abbott Laboratories, Edison, New Jersey. He has expertise in contract manufacturing, logistics and supply chain management, process improvement, strategic sourcing, manufacturing management, capacity optimization, and new product launch management.

Senior Solution Architect ClearOrbit

As the Senior Solution Architect, Woolf is responsible for responsible for creating functional designs, building business cases, evaluating investment options and launching products. Woolf has been a ClearOrbit employee since 1999 and previously held the title of Director of Product Management.

Prior to ClearOrbit, Woolf worked at Sheshunoff Information Services as a
Financial Analyst and a Business System Developer.

Woolf holds a BBA from the University of Texas in Finance.

Supply Chain Manager Daiichi Sankyo

Jeff Simmons is currently Manager of Manufacturing Services at Daiichi Sankyo, Inc., Parsippany, NJ. He is responsible for managing the business relationship with several contract manufacturers to assure execution of the company’s marketing plan while maintaining regulatory compliance and compliance with contractual obligations. He is a licensed Professional Engineer and is APICS certified in Production and Inventory Control.

Chief Operating Officer DDN (Drug Distribution Network)

Mark Wiesman has more than 20 years of broad staff and line management experience including finance, public accounting, consulting, information technology, operations management and general management. Wiesman has a master’s in business administration from Northwestern University’s Kellogg Graduate School of Management. He has extensive experience in strategic planning, mergers and acquisitions, financial modeling, systems implementation and manufacturing and distribution management. Prior to joining DDN Pharmaceutical Logistics in 2007, Wiesman was vice president and general manager of a plastics medical products business.

Vice President of Sales & Marketing DDN (Drug Distribution Network)

Michael Bartholomew joined DDN Pharmaceutical Logistics in 2006. He has more than 17 years of broad life science sales and management experience including primary care sales, hospital sales, sales training, government account management, managed care, large Group-Purchasing Organization account management, and developing specialty sales teams. Bartholomew worked for Pfizer, Pharmacia, and Baxter before becoming vice president of sales & marketing at a small commercial concern in Wisconsin. He led them to considerable growth, which allowed them to be acquired. Bartholomew served as DDN's Director of Sales & Account Management before his promotion in 2007. Bartholomew proudly served in the United States Air Force as an aviator, holding the rank of Captain. He flew 33 combat and close-combat support missions during Desert Storm. He received his bachelor’s degree in economics from Indiana University and is completing his master’s of science degree in (healthcare) administration from Central Michigan University, where he will graduate with honors.

Dr. Eisenstein is a member of the Duke Clinical Research Institute’s Outcomes Research and Assessment Group, with special expertise in novel techniques for complex clinical- economic modeling, large-scale databases, medical cost accounting, and decision support systems. His major research interests include burden of illness studies; new technology assessment; cost-finding, decision analytic, and cost-effectiveness model development; clinical and economic provider profiling; and the introduction of evidence-based techniques for health care education and management.

Currently, Dr. Eisenstein is directing studies that assess the economic attractiveness of percutaneous coronary intervention (PCI) in hospitals with on-site cardiac surgery versus without on-site cardiac surgery, and investigate the outcomes of acute coronary syndrome patients who undergo percutaneous coronary intervention with an emphasis on risk prediction models. He is also involved in several studies that are investigating the use of health information technology in community settings.

Dr. Eisenstein’s research in clinical-economic databases and their analysis has been enhanced through his work as principal investigator for phase II, III, and IV pharmacoeconomic studies conducted along side clinical trials in cardiac and emergency medicine, multi-center cardiovascular patient registries, and through his activities as Co-Convenor of the Cambell and Cochrane Collaborations Economic Methods Group.

Director of Distribution Eli Lilly & Company

Mark Seitz (Global Supply Chain Advisor) supports Lilly’s site and regional distribution operations and directly contributes to a variety of strategic logistics projects. Mark leads Lilly’s Global Logistics Lead Team, and spends considerable time assisting Lilly’s Anti-Counterfeiting Office, US Trade Relations, and Government Affairs professionals in distribution related issues such as product serialization, importation, and emerging national and state pedigree laws. He has participated on a number of PhRMA and HDMA committees and is a long time instructor of APICS Supply Chain certification courses. Mark also serves on the editorial board for Pharmaceutical Commerce magazine.

Senior Regulatory Specialist Henry Schein

Brian Loiacono came to Henry Schein in February 2004 working for their Corporate Brand Department in the Quality Assurance area. In July of 2005, he joined the Regulatory Affairs Team where he monitors, analyzes and reports to senior level management on a daily basis all relevant state and federal legislations and its impact to the wholesale distribution industry. As a Senior Regulatory Specialist, Brian performs ISO and Due Diligence audits for the company and has a keen awareness of regulatory, trade, and public affairs issues.

Product Manager, RFID Information Center IBM Software Group

Daniel G. Hernandez is the Product Manager for IBM’s WebSphere Information Center product, which includes a certified implementation of EPCIS. Since joining IBM in 2007, Daniel has been working alongside industry partners and leading companies to design and implement EPCIS based track and trace solutions. He has over 10 years of professional experience dedicated to leading, architecting, designing, and implementing industry leading sensor and mobile products and solutions. His experience spans over 50 product releases and client implementations and has worked with clients ranging from the Department of Defense to the top pharmaceutical wholesalers and manufacturers in the industry. He is coauthor of the Pharma Solution Guide, which describes an approach to pedigree law compliance using EPCIS, and serves as Editor in the GS1 EPCIS/Pedigree Accessing Task Force.

Executive Director US Supply Chain Management Novartis Pharmaceutical Company

Bill McLaury is responsible for the supply chain management process used by Novartis. He leads the groups with operational responsibility for physical distribution, warehousing, transportation, international trade management, and also all supply chain project management (i.e. product launches, acquisitions, divestitures, etc.) He has been with Novartis for over 20 years in various supply chain management positions with increasing levels of responsibility.

Senior Director Pharmacy Affairs Premier

In his present role, Pane has responsibility for coordinating the Oncology Drug Portfolio with the Premier Oncology Taskforce and oncology product line management, political advocacy, reimbursement and revenue cycle enhancement, and developing economic (ROI) models around medications, devices and the patient care environments in which they are utilized. Pane also works with pharmaceutical companies to forecast drugs in the investigational pipeline.

Before coming to Premier, Pane served as a senior consultant for Oncology Management Consulting Group, Pipersville, PA.

Prior to that, Pane held numerous hospital pharmacy positions, most recently as administrator of pharmacy services for Lehigh Valley Hospital and Health Network, Allentown, PA, where he also was chairman of the Pharmacy and Therapeutics Committee. While at Lehigh Valley Hospital, he co-developed a patient safety video that received the John Eisenberg Patient Safety award.

Pane is a member of the American College of Healthcare Executives, the American Society of Health System Pharmacists and the ASHP Section Advisory Group on Financial Management. He also holds a teaching affiliation at Wilkes University, Nesbitt College of Pharmacy.

Pane has authored a large number of articles and professional publications on topics ranging from revenue cycle management and economic modeling in health care to use of automation in hospitals, reimbursement and cost reduction. He has presented on local, state, and national levels, has served on the editorial advisory boards for numerous industry journals, and has been interviewed extensively in the national and regional media.

Pane earned a bachelor’s degree in pharmacy from St. John’s University, College of Pharmacy in Jamaica, NY, and is a fellow of the University of Pennsylvania, Leonard Davis Institute of Health Economics Executive Management Program.

The Harper Professor of Global Supply Chain Management Rider University College of Business Administration

Tan Miller is the Harper Professor of Global Supply Chain Management in the College of Business at Rider University. Previously he worked in private industry for over 20 years where most recently he was responsible for the operations of the J&J’s US Consumer Distribution Network. Prior to that, he headed the U.S. Consumer Healthcare logistics network of Pfizer Inc., and he has also held production and distribution positions with Mercer Management Consulting, Unisys, and American Olean Tile Company. Tan has published four books and over fifty articles on supply chain and logistics operations and planning. His two most recent books are titled Hierarchical Operations And Supply Chain Planning (Springer-Verlag Publishers) and Strategic Logistics: Efficient Transportation Decisions (Boskage Commerce Publications). Tan has also previously taught part-time in the MBA program of Villanova University, and has guest lectured regularly at other universities and industry forums. Tan received an M.A, M.B.A and Ph.D from the University of Pennsylvania.

Partner Taylor Wessing

Wolfgang Rehmann counts among Germany's acknowledged experts in the field of pharmaceutical and medical law. His clients include me-dium-sized and international enterprises engaged in the manufacture and distribution of pharmaceutical, medicinal or medical-technological products, as well as companies acting as consultants in that area. Wolfgang Rehmann offers both advice and forensic services to leading companies of the Life Sciences industry. His forensic work is presented before German courts and also the EU courts in Luxembourg, concen-trating on issues of pharmaceutical law, intellectual property, antitrust law and Community law.

Wolfgang Rehmann passed the first and second legal state exams in 1979 and 1982, respectively, while at the same time earning his doc-tor's degree in banking law. A member of the law firm since 1983, he became a partner in 1987. Wolfgang Rehmann is the Managing Part-ner of Taylor Wessing Germany.

Principal Tunnell Consulting

Knowledge and Experience:
With some 20 years of experience in improving manufacturing operations for a wide variety of companies, including pharmaceutical and medical device firms, Jaime has an extensive track record of enhancing operating performance through continuous improvement methodologies including Lean Manufacturing, Six Sigma, and other state-of-the-art approaches. A passionate champion of continuous improvement and team building in both start-up and turnaround environments, and an experienced management consultant, Jaime worked in global operations consulting for McKinsey & Company, and founded his own independent consulting firm. Prior to starting his consulting career, he held leadership positions for a number of companies including Vice President of Advanced Manufacturing for General Cable Corporation and Vice President of Operations for Laird Technologies.

Education:
Masters Studies, Business, University of Nebraska
B.S., Industrial Engineering, Stanford University

National Intellectual Property Rights Coordination Center U.S. Immigration & Customs Enforcement U.S. Department of Homeland Security

Senior Special Agent Craig Thurber is currently assigned to the National Intellectual Property Rights (IPR) Coordination Center in the U.S. Immigration and Customs Enforcement (ICE), Department of Homeland Security, Washington D.C. The IPR Center is a multi-agency center responsible for coordinating a unified U.S. Government response regarding IPR enforcement issues. Particular emphasis is given to protecting the public health and safety of U.S. consumers, investigating major criminal organizations engaged in transnational IPR crime, and pursuing the illegal proceeds derived from sales of counterfeit merchandise

Agent Thurber transferred to Washington D.C. in 1998 as the National Program Manager in charge of State and Local Joint Operations, then later became the West Coast Field Operations Manager. Agent Thurber also has served as the ICE Interagency Coordinator at DHS Headquarters and spent 2 years with the ICE Special Investigations Unit.

Prior to transferring to Washington D.C., Agent Thurber was with the U.S. Customs Service in San Francisco, where he specialized in Commercial Fraud and Smuggling undercover operations. In the late 80’s and early 90’s Agent Thurber pioneered techniques in IPR investigations culminating with the first successful conviction for money laundering in a fraud case against a Chinese counterfeiter in (U.S. vs. YUKA INTERNATIONAL).

Agent Thurber has been with the federal government for more than 27 years, beginning his career as an officer in the U.S. Coast Guard stationed in Washington D.C. and Seattle. In 1987 he joined the U.S. Customs Service in San Francisco and has investigated marine smuggling, commercial fraud, trade embargo, money laundering and asset removal cases.

Vice President, Industry Solutions WAM Systems

TC Baker has 20 years of experience in supply chain decision technologies. Pharmaceutical experience includes the planning and scheduling of processes ranging across primary fermentation, chemical synthesis, blood fractionation, as well as secondary dosing, formulation, and packaging. He has managed projects involving the integration of ERP systems like SAP with bolt-on APS systems and helped clients to define business process and workflows that maximize the utility of these complementary platforms for the functions for which they are designed. In his role as Vice President of Industry Solutions for WAM Systems, TC continues to assist clients to define as-is and to-be business processes, as well as value and ROI business cases.

A key result of recent benchmarking surveys by WAM shows that the pharmaceutical industry continues to trail other process industries in the adoption of best-of-breed solutions that increase visibility across the supply chain and improve coordination between headquarters planners and plant schedulers.

Vice President Global Logistics Wyeth Pharmaceuticals

Mr. Cafone is responsible for all aspects of product movement, storage, and order management activities for the Wyeth Global Pharmaceutical business. In addition, Mr Cafone ensures the supply base (including 3rd parties transportation and distribution providers) meet the approved strategies and the overall operational and business objectives of the global corporation. He is responsible for the sourcing of over $200 M worth of logistical services.

Previous to this position, Mr. Cafone was the Vice President – Technical Operations & Product Supply; Europe, Middle East, and Africa residing in the United Kingdom (2004 – 2007). In this position, Jim directed the manufacturing and supply chain function for the Europe, Middle East, and Africa. He managed four manufacturing sites with a staff of eighteen hundred personnel and a $750M operating budget. This position directly supported the sales of over $4.0 B worth of products for the pharmaceutical, over the counter, vaccines, and biopharmaceutical business units.